PURPOSE: The aim of this study was to evaluate the early clinical outcome of reconstruction with modular hemipelvic prostheses after pelvic sarcoma resection. METHODS: We retrospectively reviewed eight patients between 2004 and 2007 who had periacetabular resections and reconstruction with a modular hemipelvic prosthetic system for pelvic sarcoma with a mean follow-up of 27 (range,10~54) months. Oncology outcome was assessed with survival rate, local recurrence rate, International Society of Limb Salvage (ISOLS) score and complications. Two patients had types I and II (periacetabular and ilium) pelvic resections, three had types II and III (periacetabular and pubis) pelvic resections and three had type I , II and III (ilium, periacetabular and pubis) pelvic resections. Nobody received chemotherapy or radiotherapy. RESULTS: Five patients were free of disease; three patients died of disease. The overall survival rate was 62.5%. None had local recurrence, and 37.5% had metastasis. The mean ISOLS score was 19.5. No one had deep infection or dislocation. CONCLUSIONS: Reconstruction with a modular hemipelvic prosthetic system after periacetabular resection is a promising method because of the acceptable complication rate and satisfactory functional outcome.
PURPOSE: The aim of this study was to evaluate the early clinical outcome of reconstruction with modular hemipelvic prostheses after pelvic sarcoma resection. METHODS: We retrospectively reviewed eight patients between 2004 and 2007 who had periacetabular resections and reconstruction with a modular hemipelvic prosthetic system for pelvic sarcoma with a mean follow-up of 27 (range,10~54) months. Oncology outcome was assessed with survival rate, local recurrence rate, International Society of Limb Salvage (ISOLS) score and complications. Two patients had types I and II (periacetabular and ilium) pelvic resections, three had types II and III (periacetabular and pubis) pelvic resections and three had type I , II and III (ilium, periacetabular and pubis) pelvic resections. Nobody received chemotherapy or radiotherapy. RESULTS: Five patients were free of disease; three patients died of disease. The overall survival rate was 62.5%. None had local recurrence, and 37.5% had metastasis. The mean ISOLS score was 19.5. No one had deep infection or dislocation. CONCLUSIONS: Reconstruction with a modular hemipelvic prosthetic system after periacetabular resection is a promising method because of the acceptable complication rate and satisfactory functional outcome.
Authors: Fawzi Aljassir; Gordon P Beadel; Robert E Turcotte; Anthony M Griffin; Robert S Bell; Jay S Wunder; Marc H Isler Journal: Clin Orthop Relat Res Date: 2005-09 Impact factor: 4.176
Authors: R Windhager; J Karner; H P Kutschera; P Polterauer; M Salzer-Kuntschik; R Kotz Journal: Clin Orthop Relat Res Date: 1996-10 Impact factor: 4.176
Authors: Li Min; Longqing Li; Xin Hu; Yuqi Zhang; Jie Wang; Minxun Lu; Yong Zhou; Wenli Zhang; Yi Luo; Fan Tang; Hong Duan; Chongqi Tu Journal: Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi Date: 2022-07-15